Back To Index << Back To Terminology

# Value Set eHDSIVaccine 2026‑02‑06 16:26:57

This terminology is a snapshot as of 2026‑02‑11 10:48:51. Terminologies may evolve over time. If you need recent (dynamic) versions of this terminology, please retrieve it from the source.
Id | 1.3.6.1.4.1.12559.11.10.1.3.1.42.28 | Effective Date | 2026‑02‑06 16:26:57 Other versions this id: eHDSIVaccine202602 - as of 2026‑02‑06 16:19:05 eHDSIVaccine202602 - as of 2026‑02‑06 16:06:00 eHDSIVaccine202502 - as of 2025‑02‑17 15:33:02 eHDSIVaccine202401 - as of 2024‑01‑25 17:00:00 eHDSIVaccine202307 - as of 2023‑07‑05 13:45:00 eHDSIVaccine202301 - as of 2023‑01‑17 16:45:00 eHDSIVaccine202206 - as of 2022‑06‑23 16:00:00 eHDSIVaccine202201 - as of 2022‑01‑31 15:00:00 eHDSIVaccine202104 - as of 2021‑04‑16 16:40:00 eHDSIVaccine202006 - as of 2020‑06‑17 11:49:20 eHDSIVaccine202004 - as of 2020‑04‑22 18:30:00 epSOSVaccine201711 - as of 2017‑11‑07 14:06:20 epSOSVaccineJuly 2009 - as of 2013‑06‑03
Status | Final | Version Label | 202602
Name | eHDSIVaccine | Display Name | eHDSIVaccine
Copyright | This artefact includes content from SNOMED Clinical Terms® (SNOMED CT®) which is copyright of the International Health Terminology Standards Development Organisation (IHTSDO). Implementers of these artefacts must have the appropriate SNOMED CT Affiliate license - for more information contact http://www.snomed.org/snomed-ct/getsnomed-ct or info@snomed.org.
Usage: 5
Id | Name | Type
--- | --- | ---
Dataset
epsos-dataelement-220 | Vaccine code | DYNAMIC
epsos-dataelement-170 | Vaccine code | DYNAMIC
Template
epsos-template-145 | eHDSI Immunization Material | DYNAMIC
epsos-template-145 | eHDSI Immunization Material | DYNAMIC
epsos-template-145 | Immunization Material | DYNAMIC
2 Source Code Systems | 2.16.840.1.113883.6.73 - WHO Anatomical Therapeutic Chemical classification - FHIR: http://www.whocc.no/atc - HL7 V2: WC 2.16.840.1.113883.6.96 - SNOMED Clinical Terms - FHIR: http://snomed.info/sct - HL7 V2: SCT
Level/ Type | Code | Display Name | Code System
--- | --- | --- | ---
0‑L | 1001000221103 | Inactivated whole Vibrio cholerae antigen only vaccine product in oral dose form | SNOMED Clinical Terms
0‑L | 1011000221100 | Live attenuated Vibrio cholerae antigen only vaccine product in oral dose form | SNOMED Clinical Terms
0‑L | 1031000221108 | Human poliovirus antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 1051000221104 | Live attenuated Human poliovirus serotypes 1 and 3 antigens only vaccine product in oral dose form | SNOMED Clinical Terms
0‑L | 1052328007 | Streptococcus pneumoniae Danish serotype 4, 6B, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated only vaccine product | SNOMED Clinical Terms
0‑L | 1081000221109 | Live attenuated Rotavirus antigen only vaccine product | SNOMED Clinical Terms
0‑L | 1101000221104 | Clostridium tetani toxoid antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 1119254000 | Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens only vaccine product | SNOMED Clinical Terms
0‑L | 1119305005 | SARS-CoV-2 antigen vaccine | SNOMED Clinical Terms
0‑L | 1119349007 | SARS-CoV-2 mRNA vaccine | SNOMED Clinical Terms
0‑L | 1121000221106 | Live attenuated Yellow fever virus antigen only vaccine product | SNOMED Clinical Terms
0‑L | 1131000221109 | Vaccine product containing only inactivated whole Rabies lyssavirus antigen | SNOMED Clinical Terms
0‑L | 1157024006 | Inactivated whole SARS-CoV-2 antigen vaccine | SNOMED Clinical Terms
0‑L | 1162643001 | SARS-CoV-2 recombinant spike protein antigen vaccine | SNOMED Clinical Terms
0‑L | 1181000221105 | Influenza virus antigen only vaccine product | SNOMED Clinical Terms
0‑L | 1801000221105 | Streptococcus pneumoniae capsular polysaccharide antigen conjugated only vaccine product | SNOMED Clinical Terms
0‑L | 1861000221106 | Bacillus Calmette-Guerin antigen only vaccine product | SNOMED Clinical Terms
0‑L | 1981000221108 | Neisseria meningitidis serogroup B antigen only vaccine product | SNOMED Clinical Terms
0‑L | 2171000221104 | Salmonella enterica subspecies enterica serovar Typhi capsular polysaccharide unconjugated antigen only vaccine product in parenteral dose form | SNOMED Clinical Terms
0‑L | 2221000221107 | Live attenuated Human alphaherpesvirus 3 only vaccine product | SNOMED Clinical Terms
0‑L | 28531000087107 | COVID-19 vaccine | SNOMED Clinical Terms
0‑L | 29061000087103 | COVID-19 non-replicating viral vector vaccine | SNOMED Clinical Terms
0‑L | 37146000 | Typhus vaccine | SNOMED Clinical Terms
0‑L | 409568008 | Pentavalent botulinum toxoid vaccine | SNOMED Clinical Terms
0‑L | 428601009 | Paratyphoid vaccine | SNOMED Clinical Terms
0‑L | 601000221108 | Bordetella pertussis antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 774618008 | Whole cell Bordetella pertussis and Clostridium tetani toxoid adsorbed and Corynebacterium diphtheriae toxoid antigens only vaccine product | SNOMED Clinical Terms
0‑L | 775641005 | Clostridium tetani toxoid adsorbed and Corynebacterium diphtheriae toxoid antigens only vaccine product | SNOMED Clinical Terms
0‑L | 777725002 | Clostridium tetani toxoid antigen adsorbed only vaccine product | SNOMED Clinical Terms
0‑L | 836368004 | Bacteria antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 836369007 | Virus antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 836374004 | Hepatitis B virus antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 836375003 | Hepatitis A virus antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 836377006 | Influenza virus antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 836378001 | Japanese encephalitis virus antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 836379009 | Human papillomavirus antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 836380007 | Haemophilus influenzae type B antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 836381006 | Corynebacterium diphtheriae antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 836382004 | Measles morbillivirus antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 836383009 | Vibrio cholerae antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 836384003 | Bacillus anthracis antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 836385002 | Yellow fever virus antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 836387005 | Rotavirus antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 836388000 | Rubella virus antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 836389008 | Vaccinia virus antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 836390004 | Salmonella enterica subspecies enterica serovar Typhi antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 836393002 | Rabies lyssavirus antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 836397001 | Coxiella burnetii antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 836398006 | Streptococcus pneumoniae antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 836401009 | Neisseria meningitidis antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 836402002 | Bacillus Calmette-Guerin antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 836403007 | Tick-borne encephalitis virus antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 836495005 | Human alphaherpesvirus 3 antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 836498007 | Mumps orthorubulavirus antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 836500008 | Haemophilus influenzae type B and Neisseria meningitidis serogroup C antigens only vaccine product | SNOMED Clinical Terms
0‑L | 840549009 | Yersinia pestis antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 840563003 | Dengue virus antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 840599008 | Borrelia burgdorferi antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 863911006 | Clostridium tetani antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 871726005 | Rabies lyssavirus antigen only vaccine product | SNOMED Clinical Terms
0‑L | 871737006 | Mumps orthorubulavirus antigen only vaccine product | SNOMED Clinical Terms
0‑L | 871738001 | Live attenuated Mumps orthorubulavirus antigen only vaccine product | SNOMED Clinical Terms
0‑L | 871739009 | Human poliovirus antigen only vaccine product | SNOMED Clinical Terms
0‑L | 871740006 | Inactivated whole Human poliovirus antigen only vaccine product | SNOMED Clinical Terms
0‑L | 871742003 | Clostridium tetani antigen only vaccine product | SNOMED Clinical Terms
0‑L | 871751006 | Hepatitis A virus antigen only vaccine product | SNOMED Clinical Terms
0‑L | 871759008 | Acellular Bordetella pertussis only vaccine product | SNOMED Clinical Terms
0‑L | 871764007 | Haemophilus influenzae type b antigen only vaccine product | SNOMED Clinical Terms
0‑L | 871765008 | Measles morbillivirus antigen only vaccine product | SNOMED Clinical Terms
0‑L | 871768005 | Influenza virus antigen only vaccine product in nasal dose form | SNOMED Clinical Terms
0‑L | 871772009 | Influenza A virus subtype H1N1 antigen only vaccine product | SNOMED Clinical Terms
0‑L | 871803007 | Hepatitis A and Hepatitis B virus antigens only vaccine product | SNOMED Clinical Terms
0‑L | 871804001 | Hepatitis A virus and Salmonella enterica subspecies enterica serovar Typhi antigens only vaccine product | SNOMED Clinical Terms
0‑L | 871806004 | Haemophilus influenzae type B and Hepatitis B virus antigens only vaccine product | SNOMED Clinical Terms
0‑L | 871826000 | Clostridium tetani and Corynebacterium diphtheriae antigens only vaccine product | SNOMED Clinical Terms
0‑L | 871831003 | Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens only vaccine product | SNOMED Clinical Terms
0‑L | 871837004 | Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens only vaccine product | SNOMED Clinical Terms
0‑L | 871839001 | Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B antigens only vaccine product | SNOMED Clinical Terms
0‑L | 871866001 | Neisseria meningitidis serogroup C only vaccine product | SNOMED Clinical Terms
0‑L | 871871008 | Neisseria meningitidis serogroup A and C only vaccine product | SNOMED Clinical Terms
0‑L | 871873006 | Neisseria meningitidis serogroup A, C, W135 and Y only vaccine product | SNOMED Clinical Terms
0‑L | 871875004 | Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens only vaccine product | SNOMED Clinical Terms
0‑L | 871876003 | Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens only vaccine product | SNOMED Clinical Terms
0‑L | 871878002 | Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens only vaccine product | SNOMED Clinical Terms
0‑L | 871887006 | Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Human poliovirus antigens only vaccine product | SNOMED Clinical Terms
0‑L | 871889009 | Acellular Bordetella pertussis and Corynebacterium diphtheriae and Hepatitis B virus and inactivated whole Human poliovirus antigens only vaccine product | SNOMED Clinical Terms
0‑L | 871895005 | Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus and Human poliovirus antigens only vaccine product | SNOMED Clinical Terms
0‑L | 871908002 | Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens only vaccine product | SNOMED Clinical Terms
0‑L | 871918007 | Rickettsia antigen-containing vaccine product | SNOMED Clinical Terms
0‑L | 871921009 | Staphylococcus toxoid vaccine | SNOMED Clinical Terms
0‑L | 921000221108 | Neisseria meningitidis antigen only vaccine product | SNOMED Clinical Terms
0‑L | 971000221109 | Live attenuated Salmonella enterica subspecies enterica serovar Typhi antigen only vaccine product in oral dose form | SNOMED Clinical Terms
0‑L | 981000221107 | Streptococcus pneumoniae antigen only vaccine product | SNOMED Clinical Terms
0‑L | J07AC | Anthrax vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AC01 | anthrax antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AD | Brucellosis vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AD01 | brucella antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AE | Cholera vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AE01 | cholera, inactivated, whole cell | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AE02 | cholera, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AE51 | cholera, combinations with typhoid vaccine, inactivated, whole cell | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AF | Diphtheria vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AF01 | diphtheria toxoid | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AG | Haemophilus influenzae B vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AG01 | haemophilus influenzae B, purified antigen conjugated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AG51 | haemophilus influenzae B, combinations with toxoids | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AG52 | haemophilus influenzae B, combinations with pertussis and toxoids | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AG53 | haemophilus influenzae B, combinations with meningococcus C, conjugated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AG54 | haemophilus influenza B, combinations with meningococcus C,Y, conjugated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AH | Meningococcal vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AH01 | meningococcus A, purified polysaccharides antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AH02 | other meningococcal monovalent purified polysaccharides antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AH03 | meningococcus A,C, bivalent purified polysaccharides antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AH04 | meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AH05 | other meningococcal polyvalent purified polysaccharides antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AH06 | meningococcus B, outer membrane vesicle vaccine | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AH07 | meningococcus C, purified polysaccharides antigen conjugated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AH08 | meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AH09 | meningococcus B, multicomponent vaccine | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AH10 | meningococcus A, purified polysaccharides antigen conjugated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AH11 | meningococcus A,B,C,Y,W-135, pentavalent purified polysaccharides antigen conjugated and factor H binding protein | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AJ | Pertussis vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AJ01 | pertussis, inactivated, whole cell | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AJ02 | pertussis, purified antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AJ51 | pertussis, inactivated, whole cell, combinations with toxoids | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AJ52 | pertussis, purified antigen, combinations with toxoids | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AK | Plague vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AK01 | plague, inactivated, whole cell | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AL | Pneumococcal vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AL01 | pneumococcus, purified polysaccharides antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AL02 | pneumococcus, purified polysaccharides antigen conjugated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AL52 | pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AM | Tetanus vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AM01 | tetanus toxoid | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AM51 | tetanus toxoid, combinations with diphtheria toxoid | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AM52 | tetanus toxoid, combinations with tetanus immunoglobulin | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AN | Tuberculosis vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AN01 | tuberculosis, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AP | Typhoid vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AP01 | typhoid, oral, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AP02 | typhoid, inactivated, whole cell | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AP03 | typhoid, purified polysaccharide antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AP10 | typhoid, combinations with paratyphi types | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AR | Typhus (exanthematicus) vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AR01 | typhus exanthematicus, inactivated, whole cell | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AX | Other bacterial vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AX01 | leptospira vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BA | Encephalitis vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BA01 | encephalitis, tick borne, inactivated, whole virus | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BA02 | encephalitis, Japanese, inactivated, whole virus | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BA03 | encephalitis, Japanese, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BB | Influenza vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BB01 | influenza, inactivated, whole virus | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BB02 | influenza, inactivated, split virus or surface antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BB03 | influenza, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BB04 | influenza, virus like particles | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BB05 | influenza, RNA-based vaccine | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BB55 | influenza and covid-19, RNA-based vaccine | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BC | Hepatitis vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BC01 | hepatitis B, purified antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BC02 | hepatitis A, inactivated, whole virus | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BC20 | combinations | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BD | Measles vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BD01 | measles, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BD51 | measles, combinations with mumps, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BD52 | measles, combinations with mumps and rubella, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BD53 | measles, combinations with rubella, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BD54 | measles, combinations with mumps, rubella and varicella, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BE | Mumps vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BE01 | mumps, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BF | Poliomyelitis vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BF01 | poliomyelitis oral, monovalent, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BF02 | poliomyelitis oral, trivalent, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BF03 | poliomyelitis, trivalent, inactivated, whole virus | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BF04 | poliomyelitis oral, bivalent, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BG | Rabies vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BG01 | rabies, inactivated, whole virus | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BH | Rota virus diarrhea vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BH01 | rota virus, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BH02 | rota virus, pentavalent, live, reassorted | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BJ | Rubella vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BJ01 | rubella, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BJ51 | rubella, combinations with mumps, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BK | Varicella zoster vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BK01 | varicella, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BK02 | zoster, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BK03 | zoster, purified antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BL | Yellow fever vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BL01 | yellow fever, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BM | Papillomavirus vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BM01 | papillomavirus (human types 6, 11, 16, 18) | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BM02 | papillomavirus (human types 16, 18) | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BM03 | papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58) | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BN | Covid-19 vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BN01 | covid-19, RNA-based vaccine | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BN02 | covid-19, viral vector, non-replicating | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BN03 | covid-19, inactivated virus | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BN04 | covid-19, protein subunit | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BN05 | covid-19, virus-like particles | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BP | Chikungunya vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BP01 | chikungunya, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BP02 | chikungunya, virus-like particles | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BX | Other viral vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BX01 | smallpox and mpox vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BX02 | ebola vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BX04 | dengue virus vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BX05 | respiratory syncytial virus vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BX06 | enterovirus 71 vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA | Bacterial and viral vaccines, combined | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA01 | diphtheria-poliomyelitis-tetanus | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA02 | diphtheria-pertussis-poliomyelitis-tetanus | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA03 | diphtheria-rubella-tetanus | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA04 | haemophilus influenzae B and poliomyelitis | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA05 | diphtheria-hepatitis B-pertussis-tetanus | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA06 | diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA07 | diphtheria-hepatitis B-tetanus | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA08 | haemophilus influenzae B and hepatitis B | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA09 | diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA10 | typhoid-hepatitis A | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA11 | diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA12 | diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA13 | diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C | WHO Anatomical Therapeutic Chemical classification
0‑L | J07XA | Parasitic vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07XA01 | malaria vaccines | WHO Anatomical Therapeutic Chemical classification
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavor OTH (other) suggests text in originalText. HL7 V3: NullFlavors to appear in @nullFlavor attribute instead of @code.
| XML JSON CSV SQL SVS FHIR (4.0) [xml / json]